IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-37544-3.html
   My bibliography  Save this article

MYC reshapes CTCF-mediated chromatin architecture in prostate cancer

Author

Listed:
  • Zhao Wei

    (Qilu Hospital of Shandong University)

  • Song Wang

    (Shandong University
    Shandong Engineering & Technology Research Center for Tumor Marker Detection
    Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory)

  • Yaning Xu

    (Shandong University
    Shandong Engineering & Technology Research Center for Tumor Marker Detection
    Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory)

  • Wenzheng Wang

    (Shandong University
    Shandong Engineering & Technology Research Center for Tumor Marker Detection
    Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory)

  • Fraser Soares

    (Princess Margaret Cancer Center/University Health Network)

  • Musaddeque Ahmed

    (Princess Margaret Cancer Center/University Health Network)

  • Ping Su

    (National Administration of Health Data)

  • Tingting Wang

    (Shandong University)

  • Elias Orouji

    (Epigenetics Initiative, Princess Margaret Genomics Centre
    University of Texas MD Anderson Cancer Center)

  • Xin Xu

    (Princess Margaret Cancer Center/University Health Network)

  • Yong Zeng

    (Princess Margaret Cancer Center/University Health Network)

  • Sujun Chen

    (Princess Margaret Cancer Center/University Health Network)

  • Xiaoyu Liu

    (Shandong University
    Shandong Engineering & Technology Research Center for Tumor Marker Detection
    Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory)

  • Tianwei Jia

    (Shandong University
    Shandong Engineering & Technology Research Center for Tumor Marker Detection
    Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory)

  • Zhaojian Liu

    (Shandong University)

  • Lutao Du

    (Shandong University
    Shandong Engineering & Technology Research Center for Tumor Marker Detection
    Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory)

  • Yunshan Wang

    (Shandong University
    Shandong Engineering & Technology Research Center for Tumor Marker Detection
    Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory)

  • Shaoyong Chen

    (Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School)

  • Chuanxin Wang

    (Shandong University
    Shandong Engineering & Technology Research Center for Tumor Marker Detection
    Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory)

  • Housheng Hansen He

    (Princess Margaret Cancer Center/University Health Network
    University of Toronto)

  • Haiyang Guo

    (Shandong University
    Shandong Engineering & Technology Research Center for Tumor Marker Detection
    Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory)

Abstract

MYC is a well characterized oncogenic transcription factor in prostate cancer, and CTCF is the main architectural protein of three-dimensional genome organization. However, the functional link between the two master regulators has not been reported. In this study, we find that MYC rewires prostate cancer chromatin architecture by interacting with CTCF protein. Through combining the H3K27ac, AR and CTCF HiChIP profiles with CRISPR deletion of a CTCF site upstream of MYC gene, we show that MYC activation leads to profound changes of CTCF-mediated chromatin looping. Mechanistically, MYC colocalizes with CTCF at a subset of genomic sites, and enhances CTCF occupancy at these loci. Consequently, the CTCF-mediated chromatin looping is potentiated by MYC activation, resulting in the disruption of enhancer-promoter looping at neuroendocrine lineage plasticity genes. Collectively, our findings define the function of MYC as a CTCF co-factor in three-dimensional genome organization.

Suggested Citation

  • Zhao Wei & Song Wang & Yaning Xu & Wenzheng Wang & Fraser Soares & Musaddeque Ahmed & Ping Su & Tingting Wang & Elias Orouji & Xin Xu & Yong Zeng & Sujun Chen & Xiaoyu Liu & Tianwei Jia & Zhaojian Liu, 2023. "MYC reshapes CTCF-mediated chromatin architecture in prostate cancer," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37544-3
    DOI: 10.1038/s41467-023-37544-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-37544-3
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-37544-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Jiao Li & Kaimeng Huang & Gongcheng Hu & Isaac A. Babarinde & Yaoyi Li & Xiaotao Dong & Yu-Sheng Chen & Liping Shang & Wenjing Guo & Junwei Wang & Zhaoming Chen & Andrew P. Hutchins & Yun-Gui Yang & H, 2019. "An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis," Nature Communications, Nature, vol. 10(1), pages 1-13, December.
    2. Haiyang Guo & Yiming Wu & Mannan Nouri & Sandor Spisak & Joshua W. Russo & Adam G. Sowalsky & Mark M. Pomerantz & Zhao Wei & Keegan Korthauer & Ji-Heui Seo & Liyang Wang & Seiji Arai & Matthew L. Free, 2021. "Androgen receptor and MYC equilibration centralizes on developmental super-enhancer," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    3. Musaddeque Ahmed & Fraser Soares & Ji-Han Xia & Yue Yang & Jing Li & Haiyang Guo & Peiran Su & Yijun Tian & Hyung Joo Lee & Miranda Wang & Nayeema Akhtar & Kathleen E. Houlahan & Almudena Bosch & Stan, 2021. "CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    4. Irfan A. Asangani & Vijaya L. Dommeti & Xiaoju Wang & Rohit Malik & Marcin Cieslik & Rendong Yang & June Escara-Wilke & Kari Wilder-Romans & Sudheer Dhanireddy & Carl Engelke & Mathew K. Iyer & Xiaoju, 2014. "Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer," Nature, Nature, vol. 510(7504), pages 278-282, June.
    5. Haiyang Guo & Xinpei Ci & Musaddeque Ahmed & Junjie Tony Hua & Fraser Soares & Dong Lin & Loredana Puca & Aram Vosoughi & Hui Xue & Estelle Li & Peiran Su & Sujun Chen & Tran Nguyen & Yi Liang & Yuzhe, 2019. "ONECUT2 is a driver of neuroendocrine prostate cancer," Nature Communications, Nature, vol. 10(1), pages 1-13, December.
    6. Jing Li & Chuanliang Xu & Hyung Joo Lee & Shancheng Ren & Xiaoyuan Zi & Zhiming Zhang & Haifeng Wang & Yongwei Yu & Chenghua Yang & Xiaofeng Gao & Jianguo Hou & Linhui Wang & Bo Yang & Qing Yang & Hua, 2020. "A genomic and epigenomic atlas of prostate cancer in Asian populations," Nature, Nature, vol. 580(7801), pages 93-99, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Yanjiang Liu & Gongcheng Hu & Shengxiong Yang & Mingze Yao & Zicong Liu & Chenghong Yan & Yulin Wen & Wangfang Ping & Juehan Wang & Yawei Song & Xiaotao Dong & Guangjin Pan & Hongjie Yao, 2023. "Functional dissection of PRC1 subunits RYBP and YAF2 during neural differentiation of embryonic stem cells," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    2. Yue Deng & Yuqi Lin & Siyu Chen & Yuhang Xiang & Hongjia Chen & Shuyuan Qi & Hyung Suk Oh & Biswajit Das & Gloria Komazin-Meredith & Jean M. Pesola & David M. Knipe & Donald M. Coen & Dongli Pan, 2024. "Neuronal miR-9 promotes HSV-1 epigenetic silencing and latency by repressing Oct-1 and Onecut family genes," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    3. Jie Zhang & Gongcheng Hu & Yuli Lu & Huawei Ren & Yin Huang & Yulin Wen & Binrui Ji & Diyang Wang & Haidong Wang & Huisheng Liu & Ning Ma & Lingling Zhang & Guangjin Pan & Yibo Qu & Hua Wang & Wei Zha, 2024. "CTCF mutation at R567 causes developmental disorders via 3D genome rearrangement and abnormal neurodevelopment," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    4. Sukanya Panja & Mihai Ioan Truica & Christina Y. Yu & Vamshi Saggurthi & Michael W. Craige & Katie Whitehead & Mayra V. Tuiche & Aymen Al-Saadi & Riddhi Vyas & Shridar Ganesan & Suril Gohel & Frederic, 2024. "Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
    5. Theodore Sakellaropoulos & Catherine Do & Guimei Jiang & Giulia Cova & Peter Meyn & Dacia Dimartino & Sitharam Ramaswami & Adriana Heguy & Aristotelis Tsirigos & Jane A. Skok, 2024. "MethNet: a robust approach to identify regulatory hubs and their distal targets from cancer data," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    6. Jie Liu & Xuehua Zhong, 2024. "Epiallelic variation of non-coding RNA genes and their phenotypic consequences," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    7. Sujun Chen & Jessica Petricca & Wenbin Ye & Jiansheng Guan & Yong Zeng & Nicholas Cheng & Linsey Gong & Shu Yi Shen & Junjie T. Hua & Megan Crumbaker & Michael Fraser & Stanley Liu & Scott V. Bratman , 2022. "The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    8. Avradip Chatterjee & Brad Gallent & Madhusudhanarao Katiki & Chen Qian & Matthew R. Harter & Steve Silletti & Elizabeth A. Komives & Michael R. Freeman & Ramachandran Murali, 2024. "The homeodomain regulates stable DNA binding of prostate cancer target ONECUT2," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    9. Goutam Chakraborty & Kasmira Gupta & Natasha Kyprianou, 2023. "Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer," Nature Communications, Nature, vol. 14(1), pages 1-4, December.
    10. Ning Qing Liu & Irene Paassen & Lars Custers & Peter Zeller & Hans Teunissen & Dilara Ayyildiz & Jiayou He & Juliane Laura Buhl & Eelco Wieger Hoving & Alexander Oudenaarden & Elzo Wit & Jarno Drost, 2023. "SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    11. Meixia Che & Aashi Chaturvedi & Sarah A. Munro & Samuel P. Pitzen & Alex Ling & Weijie Zhang & Josh Mentzer & Sheng-Yu Ku & Loredana Puca & Yanyun Zhu & Andries M. Bergman & Tesa M. Severson & Colleen, 2021. "Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    12. Reyaz ur Rasool & Caitlin M. O’Connor & Chandan Kanta Das & Mohammed Alhusayan & Brijesh Kumar Verma & Sehbanul Islam & Ingrid E. Frohner & Qu Deng & Erick Mitchell-Velasquez & Jaya Sangodkar & Aqila , 2023. "Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance," Nature Communications, Nature, vol. 14(1), pages 1-24, December.
    13. Mindy K. Graham & Rulin Wang & Roshan Chikarmane & Bulouere Abel & Ajay Vaghasia & Anuj Gupta & Qizhi Zheng & Jessica Hicks & Polina Sysa-Shah & Xin Pan & Nicole Castagna & Jianyong Liu & Jennifer Mey, 2024. "Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    14. Zifeng Wang & Scott L. Townley & Songqi Zhang & Mingyu Liu & Muqing Li & Maryam Labaf & Susan Patalano & Kavita Venkataramani & Kellee R. Siegfried & Jill A. Macoska & Dong Han & Shuai Gao & Gail P. R, 2024. "FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    15. Ting Liu & Jianan Rao & Wenting Hu & Bowen Cui & Jiaoyang Cai & Yuhan Liu & Huiying Sun & Xiaoxiao Chen & Yanjing Tang & Jing Chen & Xiang Wang & Han Wang & Wubin Qian & Binchen Mao & Sheng Guo & Rong, 2022. "Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    16. Nikolaos Giannareas & Qin Zhang & Xiayun Yang & Rong Na & Yijun Tian & Yuehong Yang & Xiaohao Ruan & Da Huang & Xiaoqun Yang & Chaofu Wang & Peng Zhang & Aki Manninen & Liang Wang & Gong-Hong Wei, 2022. "Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG," Nature Communications, Nature, vol. 13(1), pages 1-22, December.
    17. Donglin Ding & Rongbin Zheng & Ye Tian & Rafael Jimenez & Xiaonan Hou & Saravut J. Weroha & Liguo Wang & Lei Shi & Haojie Huang, 2022. "Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    18. Umut Berkay Altıntaş & Ji-Heui Seo & Claudia Giambartolomei & Dogancan Ozturan & Brad J. Fortunato & Geoffrey M. Nelson & Seth R. Goldman & Karen Adelman & Faraz Hach & Matthew L. Freedman & Nathan A., 2024. "Decoding the epigenetics and chromatin loop dynamics of androgen receptor-mediated transcription," Nature Communications, Nature, vol. 15(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37544-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.